IBDEI36K ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,50781,1,4,0)
;;=4^C78.00
;;^UTILITY(U,$J,358.3,50781,2)
;;=^5001334
;;^UTILITY(U,$J,358.3,50782,0)
;;=D57.1^^193^2497^187
;;^UTILITY(U,$J,358.3,50782,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50782,1,3,0)
;;=3^Sickle-Cell Disease w/o Crisis
;;^UTILITY(U,$J,358.3,50782,1,4,0)
;;=4^D57.1
;;^UTILITY(U,$J,358.3,50782,2)
;;=^5002309
;;^UTILITY(U,$J,358.3,50783,0)
;;=D75.1^^193^2497^185
;;^UTILITY(U,$J,358.3,50783,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50783,1,3,0)
;;=3^Polycythemia,Secondary
;;^UTILITY(U,$J,358.3,50783,1,4,0)
;;=4^D75.1
;;^UTILITY(U,$J,358.3,50783,2)
;;=^186856
;;^UTILITY(U,$J,358.3,50784,0)
;;=C90.30^^193^2497^188
;;^UTILITY(U,$J,358.3,50784,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50784,1,3,0)
;;=3^Solitary Plasmacytoma,Not in Remission
;;^UTILITY(U,$J,358.3,50784,1,4,0)
;;=4^C90.30
;;^UTILITY(U,$J,358.3,50784,2)
;;=^5001759
;;^UTILITY(U,$J,358.3,50785,0)
;;=D56.3^^193^2497^189
;;^UTILITY(U,$J,358.3,50785,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50785,1,3,0)
;;=3^Thalassemia Minor
;;^UTILITY(U,$J,358.3,50785,1,4,0)
;;=4^D56.3
;;^UTILITY(U,$J,358.3,50785,2)
;;=^340497
;;^UTILITY(U,$J,358.3,50786,0)
;;=D56.9^^193^2497^190
;;^UTILITY(U,$J,358.3,50786,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50786,1,3,0)
;;=3^Thalassemia,Unspec
;;^UTILITY(U,$J,358.3,50786,1,4,0)
;;=4^D56.9
;;^UTILITY(U,$J,358.3,50786,2)
;;=^340606
;;^UTILITY(U,$J,358.3,50787,0)
;;=M31.1^^193^2497^192
;;^UTILITY(U,$J,358.3,50787,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50787,1,3,0)
;;=3^Thrombotic Microangiopathy
;;^UTILITY(U,$J,358.3,50787,1,4,0)
;;=4^M31.1
;;^UTILITY(U,$J,358.3,50787,2)
;;=^119061
;;^UTILITY(U,$J,358.3,50788,0)
;;=D51.2^^193^2497^193
;;^UTILITY(U,$J,358.3,50788,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50788,1,3,0)
;;=3^Transcobalamin II Deficiency
;;^UTILITY(U,$J,358.3,50788,1,4,0)
;;=4^D51.2
;;^UTILITY(U,$J,358.3,50788,2)
;;=^5002286
;;^UTILITY(U,$J,358.3,50789,0)
;;=D05.92^^193^2497^36
;;^UTILITY(U,$J,358.3,50789,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50789,1,3,0)
;;=3^Carcinoma in Situ Left Breast,Unspec Type
;;^UTILITY(U,$J,358.3,50789,1,4,0)
;;=4^D05.92
;;^UTILITY(U,$J,358.3,50789,2)
;;=^5001937
;;^UTILITY(U,$J,358.3,50790,0)
;;=D05.91^^193^2497^38
;;^UTILITY(U,$J,358.3,50790,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50790,1,3,0)
;;=3^Carcinoma in Situ Right Breast,Unspec Type
;;^UTILITY(U,$J,358.3,50790,1,4,0)
;;=4^D05.91
;;^UTILITY(U,$J,358.3,50790,2)
;;=^5001936
;;^UTILITY(U,$J,358.3,50791,0)
;;=D05.90^^193^2497^34
;;^UTILITY(U,$J,358.3,50791,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50791,1,3,0)
;;=3^Carcinoma in Situ Breast Unspec,Unspec Type
;;^UTILITY(U,$J,358.3,50791,1,4,0)
;;=4^D05.90
;;^UTILITY(U,$J,358.3,50791,2)
;;=^5001935
;;^UTILITY(U,$J,358.3,50792,0)
;;=D51.0^^193^2497^194
;;^UTILITY(U,$J,358.3,50792,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50792,1,3,0)
;;=3^Vitamin B12 Deficiency Anemia d/t Intrinsic Factor Deficiency
;;^UTILITY(U,$J,358.3,50792,1,4,0)
;;=4^D51.0
;;^UTILITY(U,$J,358.3,50792,2)
;;=^5002284
;;^UTILITY(U,$J,358.3,50793,0)
;;=D51.1^^193^2497^195
;;^UTILITY(U,$J,358.3,50793,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,50793,1,3,0)
;;=3^Vitamin B12 Deficiency Anemia d/t Selective Vit B12 Malabsorp w/ Proteinuria
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI36K 3748 printed Nov 22, 2024@17:52:56 Page 2
IBDEI36K ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,50781,1,4,0)
+2 ;;=4^C78.00
+3 ;;^UTILITY(U,$J,358.3,50781,2)
+4 ;;=^5001334
+5 ;;^UTILITY(U,$J,358.3,50782,0)
+6 ;;=D57.1^^193^2497^187
+7 ;;^UTILITY(U,$J,358.3,50782,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,50782,1,3,0)
+10 ;;=3^Sickle-Cell Disease w/o Crisis
+11 ;;^UTILITY(U,$J,358.3,50782,1,4,0)
+12 ;;=4^D57.1
+13 ;;^UTILITY(U,$J,358.3,50782,2)
+14 ;;=^5002309
+15 ;;^UTILITY(U,$J,358.3,50783,0)
+16 ;;=D75.1^^193^2497^185
+17 ;;^UTILITY(U,$J,358.3,50783,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,50783,1,3,0)
+20 ;;=3^Polycythemia,Secondary
+21 ;;^UTILITY(U,$J,358.3,50783,1,4,0)
+22 ;;=4^D75.1
+23 ;;^UTILITY(U,$J,358.3,50783,2)
+24 ;;=^186856
+25 ;;^UTILITY(U,$J,358.3,50784,0)
+26 ;;=C90.30^^193^2497^188
+27 ;;^UTILITY(U,$J,358.3,50784,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,50784,1,3,0)
+30 ;;=3^Solitary Plasmacytoma,Not in Remission
+31 ;;^UTILITY(U,$J,358.3,50784,1,4,0)
+32 ;;=4^C90.30
+33 ;;^UTILITY(U,$J,358.3,50784,2)
+34 ;;=^5001759
+35 ;;^UTILITY(U,$J,358.3,50785,0)
+36 ;;=D56.3^^193^2497^189
+37 ;;^UTILITY(U,$J,358.3,50785,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,50785,1,3,0)
+40 ;;=3^Thalassemia Minor
+41 ;;^UTILITY(U,$J,358.3,50785,1,4,0)
+42 ;;=4^D56.3
+43 ;;^UTILITY(U,$J,358.3,50785,2)
+44 ;;=^340497
+45 ;;^UTILITY(U,$J,358.3,50786,0)
+46 ;;=D56.9^^193^2497^190
+47 ;;^UTILITY(U,$J,358.3,50786,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,50786,1,3,0)
+50 ;;=3^Thalassemia,Unspec
+51 ;;^UTILITY(U,$J,358.3,50786,1,4,0)
+52 ;;=4^D56.9
+53 ;;^UTILITY(U,$J,358.3,50786,2)
+54 ;;=^340606
+55 ;;^UTILITY(U,$J,358.3,50787,0)
+56 ;;=M31.1^^193^2497^192
+57 ;;^UTILITY(U,$J,358.3,50787,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,50787,1,3,0)
+60 ;;=3^Thrombotic Microangiopathy
+61 ;;^UTILITY(U,$J,358.3,50787,1,4,0)
+62 ;;=4^M31.1
+63 ;;^UTILITY(U,$J,358.3,50787,2)
+64 ;;=^119061
+65 ;;^UTILITY(U,$J,358.3,50788,0)
+66 ;;=D51.2^^193^2497^193
+67 ;;^UTILITY(U,$J,358.3,50788,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,50788,1,3,0)
+70 ;;=3^Transcobalamin II Deficiency
+71 ;;^UTILITY(U,$J,358.3,50788,1,4,0)
+72 ;;=4^D51.2
+73 ;;^UTILITY(U,$J,358.3,50788,2)
+74 ;;=^5002286
+75 ;;^UTILITY(U,$J,358.3,50789,0)
+76 ;;=D05.92^^193^2497^36
+77 ;;^UTILITY(U,$J,358.3,50789,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,50789,1,3,0)
+80 ;;=3^Carcinoma in Situ Left Breast,Unspec Type
+81 ;;^UTILITY(U,$J,358.3,50789,1,4,0)
+82 ;;=4^D05.92
+83 ;;^UTILITY(U,$J,358.3,50789,2)
+84 ;;=^5001937
+85 ;;^UTILITY(U,$J,358.3,50790,0)
+86 ;;=D05.91^^193^2497^38
+87 ;;^UTILITY(U,$J,358.3,50790,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,50790,1,3,0)
+90 ;;=3^Carcinoma in Situ Right Breast,Unspec Type
+91 ;;^UTILITY(U,$J,358.3,50790,1,4,0)
+92 ;;=4^D05.91
+93 ;;^UTILITY(U,$J,358.3,50790,2)
+94 ;;=^5001936
+95 ;;^UTILITY(U,$J,358.3,50791,0)
+96 ;;=D05.90^^193^2497^34
+97 ;;^UTILITY(U,$J,358.3,50791,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,50791,1,3,0)
+100 ;;=3^Carcinoma in Situ Breast Unspec,Unspec Type
+101 ;;^UTILITY(U,$J,358.3,50791,1,4,0)
+102 ;;=4^D05.90
+103 ;;^UTILITY(U,$J,358.3,50791,2)
+104 ;;=^5001935
+105 ;;^UTILITY(U,$J,358.3,50792,0)
+106 ;;=D51.0^^193^2497^194
+107 ;;^UTILITY(U,$J,358.3,50792,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,50792,1,3,0)
+110 ;;=3^Vitamin B12 Deficiency Anemia d/t Intrinsic Factor Deficiency
+111 ;;^UTILITY(U,$J,358.3,50792,1,4,0)
+112 ;;=4^D51.0
+113 ;;^UTILITY(U,$J,358.3,50792,2)
+114 ;;=^5002284
+115 ;;^UTILITY(U,$J,358.3,50793,0)
+116 ;;=D51.1^^193^2497^195
+117 ;;^UTILITY(U,$J,358.3,50793,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,50793,1,3,0)
+120 ;;=3^Vitamin B12 Deficiency Anemia d/t Selective Vit B12 Malabsorp w/ Proteinuria
